world
UK Health Body Issues New Guidance on PMOS Diagnosis and Annual Reviews
The National Institute for Health and Care Excellence released draft recommendations calling for earlier diagnosis of polyendocrine metabolic ovarian syndrome and yearly check-ups for affected women. The guidance also advises against NHS-funded laser hair removal for related excess hair growth.
The IndependentAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The National Institute for Health and Care Excellence issued draft guidelines that call for earlier diagnosis of polyendocrine metabolic ovarian syndrome and annual health reviews for women already diagnosed with the condition. The guidance states that women with irregular or absent menstrual cycles and signs of elevated male hormones should be investigated for PMOS.
Officials said the condition affects between three and four million women in the UK and is frequently underdiagnosed.
Women diagnosed with PMOS should receive yearly appointments to monitor symptoms, assess treatment effectiveness, and address long-term health risks, according to the draft guideline. The same document states that laser or light therapies for excess hair growth linked to the condition should not be offered on the NHS, citing a potential annual cost of up to £100 million in England and insufficient evidence of cost-effectiveness.
The condition was previously called polycystic ovarian syndrome. Global experts recommended the name change after noting that emphasis on ovarian cysts had contributed to diagnostic delays. The draft guideline also includes recommendations on fertility care and mental health support for women with PMOS.
